Chinese herbal medicine for patients living with HIV in Guangxi province, China: an analysis of two registries
Anti-Retroviral Therapy (ART) is the recommended first line therapy for patients with HIV. Since 2004, Chinese government has provided free Chinese herbal medicine (CHM) for Chinese HIV/AIDS patients. Data of living patients with HIV from the NFTCMP database and Center for Disease Control (CDC) data...
Gespeichert in:
| Veröffentlicht in: | Scientific reports 2019-11, Vol.9 (1), p.17444-10, Article 17444 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 10 |
|---|---|
| container_issue | 1 |
| container_start_page | 17444 |
| container_title | Scientific reports |
| container_volume | 9 |
| creator | Sun, Jin Jiang, Feng Wen, Bin Liu, Zhen-wei Han, Mei Robinson, Nicola McGrath, Nuala Fei, Yu-tong Zhang, Ying Li, Jing Li, Wen-yuan Deng, Xin Liu, Jian-Ping |
| description | Anti-Retroviral Therapy (ART) is the recommended first line therapy for patients with HIV. Since 2004, Chinese government has provided free Chinese herbal medicine (CHM) for Chinese HIV/AIDS patients. Data of living patients with HIV from the NFTCMP database and Center for Disease Control (CDC) database during 2003–2016 in Guangxi province was obtained and compared. Patients were divided into 3 groups according to their recorded treatment regimens. A total of 2954 patients with their treatment recorded in the two databases were included for analysis, their median age was 46 years (IQR = 36–59), and 64.63% were male. CHM regimens users had baseline CD4 cell counts (380.11 ± 240.59 cell/μL), approximately 100 cell/μL significantly higher than patients receiving CHM combined with ART regimens or only ART regimens. There was no significant difference in mortality among groups. All three regimens improved patients’ CD4 cell counts. Compared to the sharp improvement in ART group during the first 6 months, CD4 cell counts of patients in CHM group and CHM combined with ART group showed a smooth and steady rise. CD4 cell counts of the combined group remained much lower than ART group in the first 3 years, but overtook ART group in the fourth year. |
| doi_str_mv | 10.1038/s41598-019-53725-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6877622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2317947024</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-efc049271225707b3ce0251cca9de3363806f9bb0171a55e9f7e58e19bbf039d3</originalsourceid><addsrcrecordid>eNp9UU1P3DAQtapWBVH-AAewxJVQf8Rx3AMSWrWAhNRLy9VyvJOsUbC3dnZZ_j0DC5RealnyaObNmzd-hBxwdsqZbL-WmivTVoybSkktVLX5QHYFq1UlpBAf38U7ZL-UW4ZHCVNz85nsSK4b3Rq1S-JsESIUoAvInRvpHcyDxwztU6ZLNwWIU6FjWIc40PswLejl1Q0NkV6sXBw2gS5zwpqHE_rE5L5RF_G68aGEQlNPp_tEMwyhTDlA-UI-9W4ssP_y7pHfP77_ml1W1z8vrmbn15WvTTtV0HtWG6G5EEoz3UkPTCjuvTNzkLKRLWt603WMa-6UAtNrUC1wTPVMmrncI2db3uWqw5U8bpHdaJc53Ln8YJML9t9KDAs7pLVtWq0bIZDgaEvgM0oP0caUneWMSW25RmWIOH4ZkdOfFZTJ3qZVxs2LFfi_ptZM1IgSrzyplAz9mwbO7JORdmukRSPts5F2g02H79W_tbzahgC5BRQsxQHy39n_oX0EuV2pZg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2317947024</pqid></control><display><type>article</type><title>Chinese herbal medicine for patients living with HIV in Guangxi province, China: an analysis of two registries</title><source>Nature Open Access</source><source>MEDLINE</source><source>NORA - Norwegian Open Research Archives</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Sun, Jin ; Jiang, Feng ; Wen, Bin ; Liu, Zhen-wei ; Han, Mei ; Robinson, Nicola ; McGrath, Nuala ; Fei, Yu-tong ; Zhang, Ying ; Li, Jing ; Li, Wen-yuan ; Deng, Xin ; Liu, Jian-Ping</creator><creatorcontrib>Sun, Jin ; Jiang, Feng ; Wen, Bin ; Liu, Zhen-wei ; Han, Mei ; Robinson, Nicola ; McGrath, Nuala ; Fei, Yu-tong ; Zhang, Ying ; Li, Jing ; Li, Wen-yuan ; Deng, Xin ; Liu, Jian-Ping</creatorcontrib><description>Anti-Retroviral Therapy (ART) is the recommended first line therapy for patients with HIV. Since 2004, Chinese government has provided free Chinese herbal medicine (CHM) for Chinese HIV/AIDS patients. Data of living patients with HIV from the NFTCMP database and Center for Disease Control (CDC) database during 2003–2016 in Guangxi province was obtained and compared. Patients were divided into 3 groups according to their recorded treatment regimens. A total of 2954 patients with their treatment recorded in the two databases were included for analysis, their median age was 46 years (IQR = 36–59), and 64.63% were male. CHM regimens users had baseline CD4 cell counts (380.11 ± 240.59 cell/μL), approximately 100 cell/μL significantly higher than patients receiving CHM combined with ART regimens or only ART regimens. There was no significant difference in mortality among groups. All three regimens improved patients’ CD4 cell counts. Compared to the sharp improvement in ART group during the first 6 months, CD4 cell counts of patients in CHM group and CHM combined with ART group showed a smooth and steady rise. CD4 cell counts of the combined group remained much lower than ART group in the first 3 years, but overtook ART group in the fourth year.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-019-53725-x</identifier><identifier>PMID: 31767895</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/174 ; 692/699/255/1901 ; Acquired immune deficiency syndrome ; Adolescent ; Adult ; Aged ; AIDS ; Anti-HIV Agents - adverse effects ; Anti-HIV Agents - therapeutic use ; Antiretroviral drugs ; Antiretroviral therapy ; CD4 antigen ; CD4 Lymphocyte Count ; Chemical and Drug Induced Liver Injury - blood ; Chemical and Drug Induced Liver Injury - etiology ; Child ; China - epidemiology ; Databases, Factual ; Drug Therapy, Combination ; Drugs, Chinese Herbal - adverse effects ; Drugs, Chinese Herbal - therapeutic use ; Female ; Follow-Up Studies ; Herbal medicine ; HIV ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; Human immunodeficiency virus ; Humanities and Social Sciences ; Humans ; Kidney Diseases - blood ; Kidney Diseases - chemically induced ; Male ; Medical disciplines: 700 ; Medisinske Fag: 700 ; Middle Aged ; multidisciplinary ; Phytotherapy ; Registries - statistics & numerical data ; Science ; Science (multidisciplinary) ; Survival Rate ; Treatment Outcome ; VDP ; Young Adult</subject><ispartof>Scientific reports, 2019-11, Vol.9 (1), p.17444-10, Article 17444</ispartof><rights>The Author(s) 2019</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>info:eu-repo/semantics/openAccess</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-efc049271225707b3ce0251cca9de3363806f9bb0171a55e9f7e58e19bbf039d3</citedby><cites>FETCH-LOGICAL-c498t-efc049271225707b3ce0251cca9de3363806f9bb0171a55e9f7e58e19bbf039d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877622/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877622/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,26572,27929,27930,41125,42194,51581,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31767895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Jin</creatorcontrib><creatorcontrib>Jiang, Feng</creatorcontrib><creatorcontrib>Wen, Bin</creatorcontrib><creatorcontrib>Liu, Zhen-wei</creatorcontrib><creatorcontrib>Han, Mei</creatorcontrib><creatorcontrib>Robinson, Nicola</creatorcontrib><creatorcontrib>McGrath, Nuala</creatorcontrib><creatorcontrib>Fei, Yu-tong</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Li, Wen-yuan</creatorcontrib><creatorcontrib>Deng, Xin</creatorcontrib><creatorcontrib>Liu, Jian-Ping</creatorcontrib><title>Chinese herbal medicine for patients living with HIV in Guangxi province, China: an analysis of two registries</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Anti-Retroviral Therapy (ART) is the recommended first line therapy for patients with HIV. Since 2004, Chinese government has provided free Chinese herbal medicine (CHM) for Chinese HIV/AIDS patients. Data of living patients with HIV from the NFTCMP database and Center for Disease Control (CDC) database during 2003–2016 in Guangxi province was obtained and compared. Patients were divided into 3 groups according to their recorded treatment regimens. A total of 2954 patients with their treatment recorded in the two databases were included for analysis, their median age was 46 years (IQR = 36–59), and 64.63% were male. CHM regimens users had baseline CD4 cell counts (380.11 ± 240.59 cell/μL), approximately 100 cell/μL significantly higher than patients receiving CHM combined with ART regimens or only ART regimens. There was no significant difference in mortality among groups. All three regimens improved patients’ CD4 cell counts. Compared to the sharp improvement in ART group during the first 6 months, CD4 cell counts of patients in CHM group and CHM combined with ART group showed a smooth and steady rise. CD4 cell counts of the combined group remained much lower than ART group in the first 3 years, but overtook ART group in the fourth year.</description><subject>692/308/174</subject><subject>692/699/255/1901</subject><subject>Acquired immune deficiency syndrome</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>AIDS</subject><subject>Anti-HIV Agents - adverse effects</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>CD4 antigen</subject><subject>CD4 Lymphocyte Count</subject><subject>Chemical and Drug Induced Liver Injury - blood</subject><subject>Chemical and Drug Induced Liver Injury - etiology</subject><subject>Child</subject><subject>China - epidemiology</subject><subject>Databases, Factual</subject><subject>Drug Therapy, Combination</subject><subject>Drugs, Chinese Herbal - adverse effects</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Herbal medicine</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>Human immunodeficiency virus</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Kidney Diseases - blood</subject><subject>Kidney Diseases - chemically induced</subject><subject>Male</subject><subject>Medical disciplines: 700</subject><subject>Medisinske Fag: 700</subject><subject>Middle Aged</subject><subject>multidisciplinary</subject><subject>Phytotherapy</subject><subject>Registries - statistics & numerical data</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>VDP</subject><subject>Young Adult</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>3HK</sourceid><recordid>eNp9UU1P3DAQtapWBVH-AAewxJVQf8Rx3AMSWrWAhNRLy9VyvJOsUbC3dnZZ_j0DC5RealnyaObNmzd-hBxwdsqZbL-WmivTVoybSkktVLX5QHYFq1UlpBAf38U7ZL-UW4ZHCVNz85nsSK4b3Rq1S-JsESIUoAvInRvpHcyDxwztU6ZLNwWIU6FjWIc40PswLejl1Q0NkV6sXBw2gS5zwpqHE_rE5L5RF_G68aGEQlNPp_tEMwyhTDlA-UI-9W4ssP_y7pHfP77_ml1W1z8vrmbn15WvTTtV0HtWG6G5EEoz3UkPTCjuvTNzkLKRLWt603WMa-6UAtNrUC1wTPVMmrncI2db3uWqw5U8bpHdaJc53Ln8YJML9t9KDAs7pLVtWq0bIZDgaEvgM0oP0caUneWMSW25RmWIOH4ZkdOfFZTJ3qZVxs2LFfi_ptZM1IgSrzyplAz9mwbO7JORdmukRSPts5F2g02H79W_tbzahgC5BRQsxQHy39n_oX0EuV2pZg</recordid><startdate>20191125</startdate><enddate>20191125</enddate><creator>Sun, Jin</creator><creator>Jiang, Feng</creator><creator>Wen, Bin</creator><creator>Liu, Zhen-wei</creator><creator>Han, Mei</creator><creator>Robinson, Nicola</creator><creator>McGrath, Nuala</creator><creator>Fei, Yu-tong</creator><creator>Zhang, Ying</creator><creator>Li, Jing</creator><creator>Li, Wen-yuan</creator><creator>Deng, Xin</creator><creator>Liu, Jian-Ping</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Research</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>3HK</scope><scope>5PM</scope></search><sort><creationdate>20191125</creationdate><title>Chinese herbal medicine for patients living with HIV in Guangxi province, China: an analysis of two registries</title><author>Sun, Jin ; Jiang, Feng ; Wen, Bin ; Liu, Zhen-wei ; Han, Mei ; Robinson, Nicola ; McGrath, Nuala ; Fei, Yu-tong ; Zhang, Ying ; Li, Jing ; Li, Wen-yuan ; Deng, Xin ; Liu, Jian-Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-efc049271225707b3ce0251cca9de3363806f9bb0171a55e9f7e58e19bbf039d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>692/308/174</topic><topic>692/699/255/1901</topic><topic>Acquired immune deficiency syndrome</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>AIDS</topic><topic>Anti-HIV Agents - adverse effects</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>CD4 antigen</topic><topic>CD4 Lymphocyte Count</topic><topic>Chemical and Drug Induced Liver Injury - blood</topic><topic>Chemical and Drug Induced Liver Injury - etiology</topic><topic>Child</topic><topic>China - epidemiology</topic><topic>Databases, Factual</topic><topic>Drug Therapy, Combination</topic><topic>Drugs, Chinese Herbal - adverse effects</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Herbal medicine</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>Human immunodeficiency virus</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Kidney Diseases - blood</topic><topic>Kidney Diseases - chemically induced</topic><topic>Male</topic><topic>Medical disciplines: 700</topic><topic>Medisinske Fag: 700</topic><topic>Middle Aged</topic><topic>multidisciplinary</topic><topic>Phytotherapy</topic><topic>Registries - statistics & numerical data</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>VDP</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Jin</creatorcontrib><creatorcontrib>Jiang, Feng</creatorcontrib><creatorcontrib>Wen, Bin</creatorcontrib><creatorcontrib>Liu, Zhen-wei</creatorcontrib><creatorcontrib>Han, Mei</creatorcontrib><creatorcontrib>Robinson, Nicola</creatorcontrib><creatorcontrib>McGrath, Nuala</creatorcontrib><creatorcontrib>Fei, Yu-tong</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Li, Wen-yuan</creatorcontrib><creatorcontrib>Deng, Xin</creatorcontrib><creatorcontrib>Liu, Jian-Ping</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>NORA - Norwegian Open Research Archives</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Jin</au><au>Jiang, Feng</au><au>Wen, Bin</au><au>Liu, Zhen-wei</au><au>Han, Mei</au><au>Robinson, Nicola</au><au>McGrath, Nuala</au><au>Fei, Yu-tong</au><au>Zhang, Ying</au><au>Li, Jing</au><au>Li, Wen-yuan</au><au>Deng, Xin</au><au>Liu, Jian-Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chinese herbal medicine for patients living with HIV in Guangxi province, China: an analysis of two registries</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2019-11-25</date><risdate>2019</risdate><volume>9</volume><issue>1</issue><spage>17444</spage><epage>10</epage><pages>17444-10</pages><artnum>17444</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Anti-Retroviral Therapy (ART) is the recommended first line therapy for patients with HIV. Since 2004, Chinese government has provided free Chinese herbal medicine (CHM) for Chinese HIV/AIDS patients. Data of living patients with HIV from the NFTCMP database and Center for Disease Control (CDC) database during 2003–2016 in Guangxi province was obtained and compared. Patients were divided into 3 groups according to their recorded treatment regimens. A total of 2954 patients with their treatment recorded in the two databases were included for analysis, their median age was 46 years (IQR = 36–59), and 64.63% were male. CHM regimens users had baseline CD4 cell counts (380.11 ± 240.59 cell/μL), approximately 100 cell/μL significantly higher than patients receiving CHM combined with ART regimens or only ART regimens. There was no significant difference in mortality among groups. All three regimens improved patients’ CD4 cell counts. Compared to the sharp improvement in ART group during the first 6 months, CD4 cell counts of patients in CHM group and CHM combined with ART group showed a smooth and steady rise. CD4 cell counts of the combined group remained much lower than ART group in the first 3 years, but overtook ART group in the fourth year.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31767895</pmid><doi>10.1038/s41598-019-53725-x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2045-2322 |
| ispartof | Scientific reports, 2019-11, Vol.9 (1), p.17444-10, Article 17444 |
| issn | 2045-2322 2045-2322 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6877622 |
| source | Nature Open Access; MEDLINE; NORA - Norwegian Open Research Archives; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA/Free Journals; Free Full-Text Journals in Chemistry |
| subjects | 692/308/174 692/699/255/1901 Acquired immune deficiency syndrome Adolescent Adult Aged AIDS Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Antiretroviral drugs Antiretroviral therapy CD4 antigen CD4 Lymphocyte Count Chemical and Drug Induced Liver Injury - blood Chemical and Drug Induced Liver Injury - etiology Child China - epidemiology Databases, Factual Drug Therapy, Combination Drugs, Chinese Herbal - adverse effects Drugs, Chinese Herbal - therapeutic use Female Follow-Up Studies Herbal medicine HIV HIV Infections - drug therapy HIV Infections - epidemiology Human immunodeficiency virus Humanities and Social Sciences Humans Kidney Diseases - blood Kidney Diseases - chemically induced Male Medical disciplines: 700 Medisinske Fag: 700 Middle Aged multidisciplinary Phytotherapy Registries - statistics & numerical data Science Science (multidisciplinary) Survival Rate Treatment Outcome VDP Young Adult |
| title | Chinese herbal medicine for patients living with HIV in Guangxi province, China: an analysis of two registries |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T07%3A00%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chinese%20herbal%20medicine%20for%20patients%20living%20with%20HIV%20in%20Guangxi%20province,%20China:%20an%20analysis%20of%20two%20registries&rft.jtitle=Scientific%20reports&rft.au=Sun,%20Jin&rft.date=2019-11-25&rft.volume=9&rft.issue=1&rft.spage=17444&rft.epage=10&rft.pages=17444-10&rft.artnum=17444&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-019-53725-x&rft_dat=%3Cproquest_pubme%3E2317947024%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2317947024&rft_id=info:pmid/31767895&rfr_iscdi=true |